Reporting the counterparty's growth as its own: management explains the company's coming year by narrating what its cust
The model's full reasoning — Q2 2017 call → NO我们根据提供的财报电话会议记录,判断管理层是否通过叙述其交易对手(客户)自身的扩张来讲述公司业务走向。关键点:管理层是否大量描述特定客户自己的增长、扩张、采用等,并将公司未来活动归因于这些客户的轨迹,且公司已嵌入其中,且该轨迹处于早期且规模大。 在记录中,管理层多次提到: - FOX-XP系统用于光学设备,客户是“lead customer”,已购买工程配置系统,正在演示烧录,预计夏季需要产能,但时间略有推迟。 - 提到“initial lead customer”需要系统支持生产烧录,但时间从第一季度末推迟到夏季。 - 提到“we continue to engage with our initial lead customer”,并说“we are successfully demonstrating burn-in of their devices on the FOX-XP system in our factory today”。 - 还提到“we’ve received information from this customer that implies a slightly later ramp”,以及“capacity shipments needed in the upcoming summer of 2017”。 - 此外,提到“we are taking several steps to shorten our lead times and ensure we have the capacity to meet a range of capacity needs and forecasts”。 - 还提到“we continue to be very excited about the sensor and photonics markets”,但更多是市场层面。 管理层确实在描述一个特定客户(lead customer)的产能需求时间线,并说公司正在为此做准备。但注意:该客户的需求被推迟了,且管理层说“could change on short notice”。此外,管理层也提到其他机会,但主要焦点是这个客户。 问题在于:管理层是否将公司前景主要描述为跟随该客户的扩张?管理层说“we remain optimistic about the opportunity to address this customer’s needs that span across multiple programs and applications”,但同时也提到其他市场。然而,在电话会议中,管理层确实花了不少篇幅谈论这个客户的需求时间线,并说公司正在准备产能以应对。但该客户的需求被推迟,且尚未有订单?实际上,该客户已经购买了工程系统,但生产系统尚未订购?管理层说“we are currently building several systems in anticipation of the need for shorter lead times”,但并未明确说已收到订单。此外,管理层说“we expect to ship our initial FOX-XP test cell in the current fiscal third quarter”,但那是针对另一个应用(光学设备)?实际上,管理层说“This system is configured for testing 18 wafers in parallel...
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| EMKR | EMCORE Corporation | Q4 2023 | 2023-12-12 | C+ |
| MBLY | Mobileye Global Inc. | Q2 2023 | 2023-07-28 | B+ |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| ILMN | Illumina, Inc. | Q1 2018 | 2018-04-24 | A |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| FNV | Franco-Nevada Corporation | Q3 2016 | 2016-11-08 | B+ |
| HXL | Hexcel Corporation | Q4 2015 | 2016-01-22 | B+ |
OOMA · Q3 2022 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future volume as a consequence of those parties' trajectories.
MBLY · Q2 2023 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's volume as a consequence of those parties' trajectories.
ILMN · Q1 2018 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future as a consequence of those parties' trajectories.